The health of Advanced Cell Technology (ACT) is still, I think, a fair barometer of support and funding for embryonic stem cell research. The latest from UPI: ''Advanced Cell Technology said Friday it has closed two financings generating approximately $13 million in cash. ... ACT said it would also use the proceeds toward three therapeutic ...